Atezolizumab monotherapy versus chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (IMvigor130): final overall survival analysis from a randomised, controlled, phase 3 study
Titel:
Atezolizumab monotherapy versus chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (IMvigor130): final overall survival analysis from a randomised, controlled, phase 3 study
Auteur:
Bamias, Aristotelis Davis, Ian D Galsky, Matthew D Arranz, José Á Kikuchi, Eiji Grande, Enrique del Muro, Xavier Garcia Park, Se Hoon De Giorgi, Ugo Alekseev, Boris Mencinger, Marina Izumi, Kouji Schutz, Fabio A Puente, Javier Li, Jian-Ri Panni, Stefano Gumus, Mahmut Özgüroğlu, Mustafa Mariathasan, Sanjeev Poloz, Yekaterina Bene-Tchaleu, Fabiola Lee, Chooi Bernhard, Sandrine De Santis, Maria